Comparer des méthodes

	Questionnaire d'Impact de la Fibromyalgie	Questionnaire sur la maladie de Parkinson-39
Domaine	Résultats de santé	Résultats de santé
Famille	Process / pipeline	Process / pipeline
Année d'origine	1991	1997
Auteur d'origine	Cynthia S. Burckhardt et al.	Crispin Jenkinson et al.
Type	Self-report symptom and functional impairment questionnaire	Self-report quality of life questionnaire
Source fondatrice	Burckhardt, C. S., Clark, S. R., & Bennett, R. M. (1991). The Fibromyalgia Impact Questionnaire: Development and validation. The Journal of Rheumatic Diseases, 18(5), 728-735.	Jenkinson, C., Fitzpatrick, R., Peto, V., Greenhall, R., & Hyman, N. (1997). The Parkinson's Disease Questionnaire (PDQ-39): Development and validation of a Parkinson's disease summary index score. Age and Ageing, 26(5), 353-357.
Alias	FIQ, Fibromyalgia Impact, Fibromyalgia Questionnaire	PDQ-39, Parkinson's Disease Questionnaire, PDQ
Apparentées	4	4
Résumé	The FIQ is the most widely used patient-reported outcome measure for fibromyalgia disease burden. Developed by Cynthia Burckhardt and colleagues in 1991, this 10-item questionnaire quantifies how fibromyalgia affects physical function, work capacity, depression, anxiety, sleep, pain, and fatigue. The revised version (FIQR, 21 items) offers enhanced psychometric properties and is the current standard in fibromyalgia clinical trials and practice.	The PDQ-39 is the most widely used patient-reported outcome measure for Parkinson's disease quality of life. Developed by Crispin Jenkinson and colleagues in 1997, this 39-item self-report questionnaire comprehensively assesses how Parkinson's symptoms affect daily functioning, emotional well-being, stigma, social support, and cognitive-communication abilities. It is the recommended instrument in major Parkinson's disease clinical trials and forms a core component of outcome measurement in movement disorders.